Tasly Pharmaceutical
Tasly Modern TCM Garden
Beichen Hi-Tech Park
Tianjin
300410
China
Tel: 0086-22-2673-6808
Website: http://www.taslyusa.com/
19 articles about Tasly Pharmaceutical
-
Transgene Completes the Sale of the Greater China Rights of TG6002 and TG1050 to Tasly Biopharmaceuticals for $48 Million in Newly-Issued Shares
8/20/2018
Transgene today announces the completion of the transactions signed with Tasly Biopharmaceuticals. Co. Ltd. on July 10, 2018.
-
Transgene and Tasly Biopharmaceuticals Conclude Strategic Agreements for the Rights of Transgene’s Virus-Based Immunotherapies TG6002 and TG1050 in Greater China
7/10/2018
Transgene to receive $48 million paid in newly created Tasly Biopharmaceuticals shares
-
Pharnext Announces PXT3003 was Granted Priority Review by the China Food and Drug Administration
6/14/2018
Pharnext SA today announced that PXT3003 was granted priority review for Charcot-Marie-Tooth Type 1A disease (CMT1A) by the China Food and Drug Administration (CFDA).
-
Suzhou's PegBio Raises $20 Million From Tasly Pharmaceutical
7/18/2017
-
PHARNEXT Announces Strategic Partnership With Tasly Pharmaceutical, A Leading Chinese Pharmaceutical Group
5/10/2017
-
Tasly Pharmaceutical Opens U.S. Headquarters In Maryland
9/8/2014
-
Tasly Pharmaceutical Brings A Scientific Revolution To North America
8/28/2014
-
TRANSGENE-Tasly Pharmaceutical JV Reports Immunotherapy Progress
7/2/2014
-
TRANSGENE Announces Presentation Of Data On TG1050 Immunotherapy Against Chronic Hepatitis B And Provides Update On Its Joint Venture With Tasly Pharmaceutical In China
7/1/2014
-
Week in Review: Tasly Pharmaceutical Buys Stake in TCM Maker for $25 Million
10/7/2013
-
Tasly Pharmaceutical Pays $45 Million for Stake in New Century Pharma
10/4/2013
-
Tasly Pharmaceutical Buys 100% of TaslyDiyi Pharma
4/22/2013
-
TRANSGENE and Tasly Pharmaceutical JV Starts Operations With Four Transgene Molecules
7/27/2012
-
Tasly Pharmaceutical Selects ICON as it Seeks First FDA Approval of a Traditional Chinese Medicine
11/21/2011
-
The Week in Review: Tasly Pharmaceutical to Build US Manufacturing Facility
6/6/2011
-
Chinese Biotech Company Tasly Pharmaceutical to Invest $40 Million in MontCo
6/3/2011
-
ProteoTech and Tasly Pharmaceutical Announce Alzheimer's Disease Drug Development Agreement for Exebryl-1(R)
10/4/2010
-
Tasly Pharmaceutical to Start Phase III Trial of TCM Angina Treatment in US
8/9/2010
-
Tasly Pharmaceutical and TRANSGENE Form JV
5/19/2010